Changes in Body Composition Using Automated CT-Based AI Tools After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy

Full article: Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy

Kamyar Ghabili, MD, discusses the AJR article by Nelson et al. identifying patterns of changes in CT-based body composition measures after initiation of semaglutide therapy.